| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516595A Patch for transcutaneous immunization |
| 07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515319A Induction of cytotoxic T lymphocyte response |
| 07/28/2004 | CN1515286A Chinese medicinal herb extractive |
| 07/28/2004 | CN1515263A Phytosterol and phytosterol-beta-D-heteroside preparation and its application |
| 07/28/2004 | CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease |
| 07/28/2004 | CN1515253A New application of 1,3-propylene glycol derivative |
| 07/28/2004 | CN1515251A Composition with function of beautifying face and its application |
| 07/28/2004 | CN1515248A Urea derivative used as inosine-5'-dehydrogenase monophosphate inhibitor |
| 07/28/2004 | CN1515245A Vaccine containing saponin and sterol |
| 07/28/2004 | CN1159327C Oligose with anticancer activity used as medicines or health-care products to improve immunity |
| 07/28/2004 | CN1159313C Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition |
| 07/28/2004 | CN1159299C Arylakylpyridzinones |
| 07/28/2004 | CN1159293C 5-aroylnaphthalene derivatives |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159277C New intermediate for preparation of anti-histamine piperdine derivatives |
| 07/28/2004 | CN1159039C Capsule, oral liquid and face mask with health care function |
| 07/28/2004 | CN1159025C Chinese medicine for optimally taking care of brain health |
| 07/28/2004 | CN1159024C Perfume incense oil composition easy to be absorbed by body and its preparation and use |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159013C Use of combination of vitamins for the treatment of pruritus and relating to itching and/or non-infective inflammatory disorders |
| 07/28/2004 | CN1159012C Pharmaceutical composition of combination of piperidinoalkanol-decongestant |
| 07/28/2004 | CN1158997C A process for the preparation of suspensions of drug particles for inhalation delivery |
| 07/28/2004 | CN1158996C Medicinal aerosol formulations |
| 07/27/2004 | US6767996 Altered antibodies and their preparation |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767908 Treatment of cytokine mediated diseases such as arthritis. |
| 07/27/2004 | US6767555 A cyclosporin-containing composition in the form of a capsule consists of a polyoxyethylene sorbitan fatty acid ester, a reaction product of a natural or hydrogenated castor oil, ethylene oxide, a sorbitan fatty ester, and ethanol |
| 07/27/2004 | US6767533 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2279999C The neurotrophic factor nnt-1 |
| 07/22/2004 | WO2004061115A1 PROCESS FOR PRODUCING SOLUBLE β-GLUCAN HAVING IMMUNOLOGICAL FUNCTION AND USE THEREOF |
| 07/22/2004 | WO2004061106A1 Novel mammal-origin protein negatively regulating the expression of antigen presentation-associated molecule such as b7-2 molecule or mhc class ii molecule on cell surface and utilization of the same |
| 07/22/2004 | WO2004061101A1 Method of selecting novel immunosuppressant |
| 07/22/2004 | WO2004061090A1 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same |
| 07/22/2004 | WO2004061089A1 Dendritic cell line |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060893A1 Pyrrolopyridine potassium channel openers |
| 07/22/2004 | WO2004060881A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof |
| 07/22/2004 | WO2004060875A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 07/22/2004 | WO2004060262A2 Modulators of notch signalling for use in immunotherpapy |
| 07/22/2004 | WO2004043456A8 Cholesterol absorption inhibitors for the treatment of demyelination |
| 07/22/2004 | WO2004039978A3 Human chondroosteomodulin (tig2), production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/22/2004 | WO2004035086A3 Method for treatment of demyelinating central nervous system disease using gm-csf |
| 07/22/2004 | WO2004027049B1 Methods and compositions to generate and control the effector profile of t cells by simultaneous loading and activation of selected subsets of antigen presenting cells |
| 07/22/2004 | WO2004024086A3 Compounds, compositions and methods |
| 07/22/2004 | WO2004022079A8 Method for reinstalling control system for antigenic homeostasis of mammalian organisms (effect of kukharchuk-radchenko-sirman) |
| 07/22/2004 | WO2004019974A3 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 07/22/2004 | WO2004014418A3 Neisserial vaccine compositions comprising a combination of antigens |
| 07/22/2004 | WO2004014417A3 Vaccine compositions comprising l2 and/or l3 immunotype lipooligosaccharides from lgtb- neisseria minigitidis |
| 07/22/2004 | WO2003077863A3 Method for overexpression of zwitterionic polysaccharides |
| 07/22/2004 | WO2003072135A3 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors |
| 07/22/2004 | WO2003028668A3 Gammaglobulin treatment of immune disorders |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | WO2002088090A3 Pyrazole derived kinase inhibitors |
| 07/22/2004 | WO2002078637A3 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid a (3d-mla) |
| 07/22/2004 | WO2002074239A3 Compositions and methods for the treatment and clinical remission of psoriasis |
| 07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
| 07/22/2004 | US20040143014 Therapeutic use of alpha-2-delta ligands |
| 07/22/2004 | US20040142994 bronchitis; chronic obstructive pulmonary disease; rhinitis; antihistamines; antiallergens; antipyretics |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142976 Modulation cytokine sensitive diseases, cellular adhesion molecules; Aids therapy; antihistamines; antiarthritic agents; bone disorders; malaria; cachexia; Crohn's disease |
| 07/22/2004 | US20040142960 Yohimbine as immunobiologically active agent |
| 07/22/2004 | US20040142952 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, medicinal compositions, adenosine a3 receptor affinity agents, ocular tension lowering agents, preparations for preventing and treating glaucoma and method of lowering ocular tension |
| 07/22/2004 | US20040142947 Pyrrolopyrimidines |
| 07/22/2004 | US20040142934 treatment of rheumatoid arthritis and/or pain; INHIBIT activity of VEGF receptor tyrosine kinase and VEGF-dependent cell proliferation |
| 07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
| 07/22/2004 | US20040142931 inhibit the tyrosine kinase activity of growth factor receptors such as HER1, HER2, and HER4 |
| 07/22/2004 | US20040142927 Inhibitors of p38 |
| 07/22/2004 | US20040142920 acute or chronic transplant rejection or inflammatory or autoimmune diseases |
| 07/22/2004 | US20040142912 Treatment of systemic lupus erythematosis |
| 07/22/2004 | US20040142881 sulfofucosylacylglycerol derivatives |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142432 Preparing single chain antibodies comprised of camelid subunits for treating and preventing inflammation, allergies, cancer, infections, transplant rejection, autoimmune and muscular disorders |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142404 Designing cyclic peptide which modulates tyrosine kinase activity and can be used as potential treatment for asthma, eczema, food allergies, cancer, inflammatory bowel and autoimmune diseases; enzyme inhibitors |
| 07/22/2004 | US20040142391 Methods for determining whether a compound is capable of inhibiting the interaction of a peptide with RAGE |
| 07/22/2004 | US20040142047 Korean acanthopanax senticosus extract, protein extract, crude protein-polysaccharide which were extracted from korean acanthopanax senticosus, and immunoregulating compositions comprising the same and use thereof |
| 07/22/2004 | US20040142000 Immune activator |
| 07/22/2004 | US20040141992 derived from the same antigen as the substance eliciting the allergic reaction; contains an epitope different from that evoking the allergic reaction, yet does not elicit the allergic reaction |
| 07/22/2004 | US20040141973 IPG antagonists for the treatment of conditions involving mast cells, basophils and eosinophils |
| 07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
| 07/22/2004 | US20040141958 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte |
| 07/22/2004 | US20040141947 Method for treatment of demyelinating central nervous system disease |
| 07/22/2004 | US20040141944 polymer synthesized by a cross-coupling reaction of polymer scaffold units and xenoantigens |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | DE10085496T5 Extrakte von Betelpfefferblättern als Immunmodulator Extracts of Betelpfefferblättern as an immunomodulator |
| 07/22/2004 | CA2512002A1 Method of selecting novel immunosuppressant |
| 07/21/2004 | EP1439226A2 A nucleic acid antisense sequence to a polynucleotide encoding a polypeptide having heparanese activity |
| 07/21/2004 | EP1439193A2 Antibody directed to polypeptide having heparanase activity |
| 07/21/2004 | EP1439184A1 Immunological adjuvant compounds |
| 07/21/2004 | EP1439177A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 07/21/2004 | EP1438971A1 Immunopotentiators in thermotherapy for cancer |
| 07/21/2004 | EP1438966A2 Use of depsipeptide and congeners thereof as immunosuppressants for treating an infectious disease, an autoimmune disease, allergic reactions or a hyperproliferative skin disease |
| 07/21/2004 | EP1438942A1 An otorhinological drug delivery device |
| 07/21/2004 | EP1438583A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |